Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zimmer Biomet Holdings (GB:0QQD)
LSE:0QQD
RESEARCH TOOLSreports
Zimmer Biomet Holdings (0QQD) Share Price & Analysis
0 Followers
0QQD Stock Chart & Stats
Day’s RangeCHF0 - CHF0
52-Week RangeCHF114.00 - CHF114.00
Previous CloseCHF114
Volume0.00
Average Volume (3M)N/A
Market Cap
CHF22.39B
Enterprise ValueCHF27.29B
Total Cash (Recent Filing)$415.80M
Total Debt (Recent Filing)$5.77B
Price to Earnings (P/E)24.8
BetaN/A
Next Earnings
May 02, 2024EPS Estimate
CHF1.71Last Dividend Ex-Date
Mar 27, 2024Dividend Yield0.8%
Share Statistics
EPS (TTM)4.39
Shares Outstanding205,084,022
10 Day Avg. Volume159
30 Day Avg. VolumeN/A
Standard Deviation0.10
R-Squared0.24
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-20.49
Price to Sales (P/S)3.81
Price to Cash Flow (P/CF)10.40
P/FCF Ratio9.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.69
Enterprise Value/Gross Profit5.14
Enterprise Value/Ebitda24.10
Forecast
1Y Price Target
CHF123.79Price Target Upside8.58% Upside
Rating ConsensusHold
Number of Analyst Covering18
Zimmer Biomet Holdings News
Bulls Say, Bears Say
Bulls Say
Cost SavingsZBH's strategic restructuring plan aims to deliver substantial cost savings, positioning the company for improved profitability and efficiency by the end of 2025.
Market PenetrationWith the commercial availability of the ROSA Shoulder System in the U.S., ZBH is poised for growth, tapping into the billion-dollar shoulder market with a groundbreaking robotic solution.
Product LaunchThe introduction of the ROSA Shoulder System, the world's first robotic surgery system for shoulder replacement, is expected to be a game changer, potentially enhancing surgical precision and improving patient outcomes.
Bears Say
Financial PerformanceHigh net debt of $6,810 million suggests significant financial leverage, which could pose risks to the company's financial stability.
Market CompetitionZimmer Biomet's loss of market share in the global recon market indicates increased competition that could challenge future earnings.
Operational ChallengesThe shortfall in U.S. Ortho and relatively flat expectations for Rosa system growth have raised concerns about the company's ability to meet ambitious growth targets.
---
Options Prices
Currently, No data available
---
Ownership Overview
35.10% Insiders
36.47% Mutual Funds
27.03% Other Institutional Investors
1.41% Public Companies and
Individual Investors
0QQD FAQ
What was Zimmer Biomet Holdings’s price range in the past 12 months?
Zimmer Biomet Holdings lowest share price was CHF114.00 and its highest was CHF114.00 in the past 12 months.
What is Zimmer Biomet Holdings’s market cap?
Currently, no data Available
When is Zimmer Biomet Holdings’s upcoming earnings report date?
Zimmer Biomet Holdings’s upcoming earnings report date is May 02, 2024 which is in 4 days.
How were Zimmer Biomet Holdings’s earnings last quarter?
Zimmer Biomet Holdings released its earnings results on Feb 08, 2024. The company reported CHF2.011 earnings per share for the quarter, beating the consensus estimate of CHF1.969 by CHF0.042.
Is Zimmer Biomet Holdings overvalued?
According to Wall Street analysts Zimmer Biomet Holdings’s price is currently Undervalued.
Does Zimmer Biomet Holdings pay dividends?
Zimmer Biomet Holdings pays a Quarterly dividend of CHF0.22 which represents an annual dividend yield of 0.8%. See more information on Zimmer Biomet Holdings dividends here
What is Zimmer Biomet Holdings’s EPS estimate?
Zimmer Biomet Holdings’s EPS estimate is CHF1.71.
How many shares outstanding does Zimmer Biomet Holdings have?
Zimmer Biomet Holdings has 205,084,010 shares outstanding.
What happened to Zimmer Biomet Holdings’s price movement after its last earnings report?
Zimmer Biomet Holdings reported an EPS of CHF2.011 in its last earnings report, beating expectations of CHF1.969. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Zimmer Biomet Holdings?
Among the largest hedge funds holding Zimmer Biomet Holdings’s share is Dodge & Cox. It holds Zimmer Biomet Holdings’s shares valued at 1B.
---
Zimmer Biomet Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
CHF123.79 (8.58% Upside)
CHF123.79 (8.58% Upside)
Blogger Sentiment
Bullish
GB:0QQD Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $3.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.52%
12-Months-Change
Fundamentals
Return on Equity
8.36%
Trailing 12-Months
Asset Growth
2.05%
Trailing 12-Months
Company Description
Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company engages in designing, manufacturing and marketing orthopedic reconstructive products; biologics, sports medicine, extremities and trauma products; spine, dental implants, bone healing, craniomaxillofacial and thoracic products; and related surgical products.
---
0QQD Earnings Call
Q4 2024
0:00 / 0:00
---
0QQD Net sales Breakdown
41.09% Knees
26.60% Hips
23.70% S.E.T
8.60% Other
---
0QQD Stock 12 Months Forecast
Average Price Target
CHF123.79
▲(8.58% Upside)
Technical Analysis
Zimmer Biomet Holdings
―
Abbott Labs
―
Johnson & Johnson
―
Medtronic
―
Baxter International
―
Best Analysts Covering 0QQD
1 Year
1 Year Success Rate
29/42 ratings generated profit
1 Year Average Return
+6.68%
assigned a buy rating 5 days ago
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 69.05% of your transactions generating a profit, with an average return of +6.68% per trade.
---